Sign in

CIK 0001478320

  • Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
270907024
Phone
+1 206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale SVP and General Counsel sold 4,166 shares at $41.93 ($174,680)
  2. 4 Open-market sale Chief Scientific Officer sold 27,265 shares at an average $41.56 ($1,133,212)
  3. 4 Open-market sale SVP, Diagnostics, T-Detect sold 1,301 shares at $41.25 ($53,666)
  4. 4 Open-market sale Chief People Officer sold 2,000 shares at $43.04 ($86,080)
  5. 4 Open-market sale Chief Medical Officer sold 2,000 shares at $44.50 ($89,000)
  6. 4 Open-market sale Director sold 4,500 shares at $43.41 ($195,345)
  7. 4 Open-market sale Chief Operating Officer sold 3,586 shares at $42.34 ($151,831)
  8. 4 Open-market sale Chief Financial Officer sold 20,000 shares at an average $41.30 ($826,005)
  9. 4 Open-market sale CEO and Chairman sold 15,000 shares at an average $41.81 ($627,107)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale SVP and General Counsel sold 4,167 shares at $40.00 ($166,680)
  12. 4 Open-market sale Chief Scientific Officer sold 19,475 shares at an average $40.36 ($786,061)
  13. 4 Grant or award Director acquired 4,443 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale SVP, Diagnostics, immunoSEQ Dx sold 16,052 shares at an average $43.58 ($699,560)
  16. 4 Open-market sale CEO and Chairman sold 15,000 shares at an average $42.89 ($643,416)
  17. 4 Grant or award Director acquired 4,443 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale Director sold 6,000 shares at an average $43.06 ($258,363)
  20. 4 Open-market sale Chief Business Development Off sold 1,354 shares at an average $41.69 ($56,451)

Page 13 of 28 · 544 filings